New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
16:27 EDTCOV, MDT, FIO, SNDK, DWA, KPTI, BLUEOn The Fly: Closing Wrap
Stocks on Wall Street were slightly higher as M&A news competed with Iraq for headlines. There was little reaction to the day’s economic data, including industrial production in May and the Empire State manufacturing report for June. The averages moved in a narrow range near the flat-line throughout the session, with each of the major averages managing to notch small gains. ECONOMIC EVENTS: In the U.S., industrial production increased 0.6% in May, versus an expected increase of 0.5%, while capacity utilization rose slightly to 79.1%. The NY Fed Empire state survey for June ticked up to a four-year high of 19.3, which was higher than expected. The NAHB homebuilder survey index climbed to 49 in June, beating expectations for it to rise from its previous reading of 45 to 47. COMPANY NEWS: A number of merger and acquisition deals were announced, headlined by a another pharmaceutical industry mega-merger. Medtronic (MDT) agreed to acquire Ireland's Covidien (COV) in a cash-and-stock transaction valued at $93.22 per Covidien share, or a total of approximately $42.9B based on Medtronic's closing stock price on June 13. Following the deal announcement, Covidien shares trading in New York rose $14.73, or 20.45%, to $86.75. Medtronic, which also raised its dividend by 9% this morning, was upgraded at both William Blair and JPMorgan, though its shares declined 67c, or 1.1%, to $60.03. MAJOR MOVERS: Among the notable gainers was Bluebird bio (BLUE), which surged $8.37, or 32.08%, to $34.46 after reporting data that Piper Jaffray believes solidifies LentiGlobin prospects in one indication and positions it attractively for another indication that is also being pursued for the drug. Also higher was Fusion-io (FIO), which jumped $2.08, or 22.41%, to $11.36, which was above the $11.25 per share in cash that SanDisk (SNDK) agreed to pay to acquire the company. Among the noteworthy losers was Karyopharm Therapeutics (KPTI), which fell $5.90, or 12.52%, to $41.22 after announcing that the FDA Center for Veterinary Medicine has found the effectiveness and safety technical sections complete to support conditional approval under a New Animal Drug Application for Karyopharm's compound Verdinexor for the treatment of canine lymphoma. As part of conditional marketing approval, the sponsor is required to conduct a full, often randomized, study, to confirm the activity of the conditionally approved agent within five years, Karyopharm noted. Also lower were shares of DreamWorks Animation (DWA), which dropped $3.00, or 10.97%, to $24.35 after its latest film, "How to Train Your Dragon 2," didn't do as well as analysts had expected in its box-office debut. INDEXES: The Dow was up 5.27, or 0.03%, to 16,781.01, the Nasdaq was up 10.45, or 0.24%, to 4,321.11, and the S&P 500 was up 1.62, or 0.08%, to 1,937.78.
News For COV;MDT;FIO;SNDK;DWA;KPTI;BLUE From The Last 14 Days
Check below for free stories on COV;MDT;FIO;SNDK;DWA;KPTI;BLUE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 16, 2014
10:36 EDTMDT, COVTreasury calls on Congress to halt inversion deals
Subscribe for More Information
08:03 EDTSNDK, FIOSanDisk announces expiration of HSR waiting period for Fusion-io purchase
Subscribe for More Information
07:59 EDTMDT, COVTreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
07:18 EDTMDTScoliosis Research Society to hold annual meeting
Subscribe for More Information
06:56 EDTSNDKSanDisk volatility increases into Q2 and outlook
SanDisk July call option implied volatility is at 79, August is at 38, October is at 34; compared to its 26-week average of 30 according to Track Data, suggesting large near term price movement in the expected release of Q2 results after the market close on July 16.
06:16 EDTSNDKSanDisk partners with Rockchip for iNAND solutions, DigiTimes reports
Subscribe for More Information
July 15, 2014
15:45 EDTSNDKSanDisk technical comments ahead of earnings
Subscribe for More Information
09:05 EDTSNDKSanDisk to benefit from Amazon use of flash storage, says Pacific Crest
Subscribe for More Information
July 14, 2014
15:38 EDTSNDKSanDisk July volatility increases into Q2 and outlook
SanDisk July call option implied volatility is at 64, August is at 37, October is at 34; compared to its 26-week average of 30 according to Track Data, suggesting large near term price movement in the expected release of Q2 results after the market close on July 16.
10:00 EDTDWA, COVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:31 EDTSNDKSanDisk price target raised to $114 from $95 at Stifel
Stifel raised its price target on SanDisk as the firm expects the company's June quarter results to beat consensus estimates. The firm predicts that SanDisk's guidance for its September quarter may also beat expectations. Stifel believes that demand is shifting towards SanDisk's high valued products, and it keeps a Buy rating.
07:12 EDTMDT, COVCovidien downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
06:54 EDTDWADreamWorks Animation downgraded at B. Riley
Subscribe for More Information
06:31 EDTCOVCovidien downgraded to Neutral from Overweight at Piper Jaffray
06:18 EDTDWADreamWorks Animation downgraded to Neutral from Buy at B. Riley
Subscribe for More Information
July 11, 2014
09:31 EDTSNDKSanDisk mentioned cautiously at ITG Research
Subscribe for More Information
09:25 EDTSNDKSanDisk remains a favorite idea at Cleveland Research
Cleveland Research continues to see upside to consensus estimates for SanDisk through 2015. The firm said demand exceeds supply, allowing SanDisk to maximize balanced profitability. Shares are Buy rated.
09:14 EDTSNDKSanDisk has several positive catalysts, says Sterne Agee
Sterne Agee expects SanDisk (SNDK) to benefit from several developments, including a strengthening high margin retail market and new Apple (AAPL) products that will include embedded MCP and SSDs. The firm expects SanDisk to report solid June quarter results and guide to a stronger September quarter. It keeps a Buy rating.
07:08 EDTSNDKSanDisk July volatility elevated at 58 into Q2 and outlook
Subscribe for More Information
July 10, 2014
08:02 EDTMDTCryoLife appoints Pat Mackin as President and CEO effective September 2
Mackin is expected to be appointed to the company's board after his employment begins. Steven Anderson will continue to serve CryoLife (CRY) as its President and Chief Executive Officer until Mackin's employment begins and then continue as its Executive Chairman. Mackin joins CryoLife from Medtronic (MDT), where he most recently served as President of Cardiac Rhythm Disease Management.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use